Scott Dunseth Myers, CEO: Viridian Therapeutics, Inc.\DE VRDN Buy · Filed 23/03/13

Trade details

Type: Insider buy
Amount: $160,325
Shares · price: 5,500 sh · $29.15 a share
Held after: 255,500 sh
Stock: Viridian Therapeutics, Inc.\DE VRDN
Person: Scott Dunseth MyersCEO
Trade date: 23/03/13
Filed: 23/03/13
Days to filing: 0 days

Holdings up 2.2%

Insiders buying this week: 1 insiders
Holding change: +2.2%

Viridian Therapeutics, Inc.\DE trades, last 26 weeks

What else happened in Viridian Therapeutics, Inc.\DE around then

Filed or reported within 30 days of the trade day · 23/02/11~23/04/12

Scott Dunseth Myers's recent trades

Scott Dunseth MyersDirector
BuyDynavax Technologies
Buy
Dynavax Technologies
DVAX
$41.1K
3,800 sh
$41.1K
Filed 25/08/25
Traded 25/08/22
Scott Dunseth MyersDirector
BuyZentalis Pharmaceuticals
Buy
Zentalis Pharmaceuticals
ZNTL
$29.4K
21,000 sh
$29.4K
Filed 25/04/30
Traded 25/04/30
Scott Dunseth MyersCEO
BuyViridian Therapeutics, Inc.\DE
Buy
Viridian Therapeutics, Inc.\DE
VRDN
$101.5K
4,000 sh
$101.5K
Filed 23/04/12
Traded 23/04/12